Systemic immunosuppressant for betterment of ocular manifestations of secondary Sjogren’s: A case report

Authors : Haleema A, Haleema A, Vasantha N, Vasantha N, Shalet Paul, Shalet Paul, Mohammed Haneef, Mohammed Haneef, Lessitha N K, Lessitha N K

DOI : 10.18231/j.ijooo.2020.051

Volume : 6

Issue : 3

Year : 2020

Page No : 226-228

Secondary sjogrens syndrome is an autoimmune disorder leading to destruction of exocrine glands with resultant classical clinical triad of dry eye, dry mouth and parotid gland enlargement in association with other systemic autoimmune diseasecommonly rheumatoid arthritis. This report highlights the unintended effect of systemic immunosuppresants given for the treatment of rheumatoid arthritis, in improving the coexistant corneal thinning and other ocular manifestation in a case ofsecondary sjogrens
syndrome, which has been rarely reported.
Key Messages: Modification of the immune response with systemic immunosuppressive agents improves severe keratoconjunctivitis sicca in recalcitrant secondary Sjogren syndrome.

Keywords: Secondary Sjogren’s, Systemic immunosuppressant, Dry eye.

 


Citation Data


Related Articles